509 related articles for article (PubMed ID: 15760377)
1. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion.
Kalinka J; Szekeres-Bartho J
Am J Reprod Immunol; 2005 Apr; 53(4):166-71. PubMed ID: 15760377
[TBL] [Abstract][Full Text] [Related]
2. The impact of dydrogesterone supplementation on serum cytokine profile in women with threatened abortion.
Kalinka J; Radwan M
Am J Reprod Immunol; 2006 Feb; 55(2):115-21. PubMed ID: 16433830
[TBL] [Abstract][Full Text] [Related]
3. Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion.
Hudić I; Fatusić Z
J Perinat Med; 2009; 37(4):338-42. PubMed ID: 19290853
[TBL] [Abstract][Full Text] [Related]
4. Dydrogesterone supplementation in women with threatened preterm delivery--the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor.
Hudić I; Szekeres-Bartho J; Fatušić Z; Stray-Pedersen B; Dizdarević-Hudić L; Latifagić A; Hotić N; Kamerić L; Mandžić A
J Reprod Immunol; 2011 Dec; 92(1-2):103-7. PubMed ID: 22032897
[TBL] [Abstract][Full Text] [Related]
5. Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome.
Polgár B; Nagy E; Mikó E; Varga P; Szekeres-Barthó J
Biol Reprod; 2004 Nov; 71(5):1699-705. PubMed ID: 15269099
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage.
Raghupathy R; Al Mutawa E; Makhseed M; Azizieh F; Szekeres-Bartho J
BJOG; 2005 Aug; 112(8):1096-101. PubMed ID: 16045524
[TBL] [Abstract][Full Text] [Related]
7. Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial.
Walch K; Hefler L; Nagele F
J Matern Fetal Neonatal Med; 2005 Oct; 18(4):265-9. PubMed ID: 16318978
[TBL] [Abstract][Full Text] [Related]
8. The role of dydrogesterone in recurrent (habitual) abortion.
Gruber CJ; Huber JC
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):426-30. PubMed ID: 16188436
[TBL] [Abstract][Full Text] [Related]
9. Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery.
Raghupathy R; Al-Mutawa E; Al-Azemi M; Makhseed M; Azizieh F; Szekeres-Bartho J
J Reprod Immunol; 2009 Jun; 80(1-2):91-9. PubMed ID: 19371956
[TBL] [Abstract][Full Text] [Related]
10. The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity.
Szekeres-Bartho J; Par G; Dombay Gy; Smart YC; Volgyi Z
Cell Immunol; 1997 May; 177(2):194-9. PubMed ID: 9178647
[TBL] [Abstract][Full Text] [Related]
11. Dydrogesterone in threatened miscarriage: a Malaysian experience.
Pandian RU
Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
[TBL] [Abstract][Full Text] [Related]
12. PIBF: the double edged sword. Pregnancy and tumor.
Szekeres-Bartho J; Polgar B
Am J Reprod Immunol; 2010 Aug; 64(2):77-86. PubMed ID: 20367622
[TBL] [Abstract][Full Text] [Related]
13. Dydrogesterone in threatened abortion: pregnancy outcome.
Omar MH; Mashita MK; Lim PS; Jamil MA
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):421-5. PubMed ID: 16293412
[TBL] [Abstract][Full Text] [Related]
14. A progesterone-induced protein increases the synthesis of asymmetric antibodies.
Kelemen K; Bognar I; Paal M; Szekeres-Bartho J
Cell Immunol; 1996 Jan; 167(1):129-34. PubMed ID: 8548836
[TBL] [Abstract][Full Text] [Related]
15. The progesterone derivative dydrogesterone abrogates murine stress-triggered abortion by inducing a Th2 biased local immune response.
Joachim R; Zenclussen AC; Polgar B; Douglas AJ; Fest S; Knackstedt M; Klapp BF; Arck PC
Steroids; 2003 Nov; 68(10-13):931-40. PubMed ID: 14667986
[TBL] [Abstract][Full Text] [Related]
16. Changes in progesterone-induced-blocking-factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks.
Salomon LJ; Rozenberg P; Szekeres-Bartho J; Malagrida L; Giudicelli Y; Ville Y
J Matern Fetal Neonatal Med; 2005 May; 17(5):353-6. PubMed ID: 16147850
[TBL] [Abstract][Full Text] [Related]
17. Effect of progesterone treatment due to threatened abortion in early pregnancy for obstetric and perinatal outcomes.
Duan L; Yan D; Zeng W; Yang X; Wei Q
Early Hum Dev; 2010 Jan; 86(1):41-3. PubMed ID: 20079582
[TBL] [Abstract][Full Text] [Related]
18. Changes of progesterone-induced blocking factor in patients after kidney transplantation.
Fekecs T; Kalmár-Nagy K; Szakály P; Németh K; Moezzi M; Zapf I; Horváth OP; Bartho-Szekeres J; Ferencz A
Transplant Proc; 2011 Dec; 43(10):3694-6. PubMed ID: 22172828
[TBL] [Abstract][Full Text] [Related]
19. Dydrogesterone support in threatened miscarriage.
El-Zibdeh MY; Yousef LT
Maturitas; 2009 Dec; 65 Suppl 1():S43-6. PubMed ID: 20007011
[TBL] [Abstract][Full Text] [Related]
20. Treatment options for threatened miscarriage.
Qureshi NS
Maturitas; 2009 Dec; 65 Suppl 1():S35-41. PubMed ID: 19945236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
